Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Feb;15(2):157-65.
doi: 10.2165/00019053-199915020-00004.

Health-related quality-of-life measurement in patients with Parkinson's disease

Affiliations
Review

Health-related quality-of-life measurement in patients with Parkinson's disease

C Jenkinson et al. Pharmacoeconomics. 1999 Feb.

Abstract

Outcome measures are increasingly used to assess the impact of diseases such as Parkinson's disease (PD) from the patient's perspective. These measures, in the form of questionnaires to assess health-related quality of life (HR-QOL), are of 2 main kinds: generic and disease-specific. The former is intended to be relevant to the widest range of health problems; the latter is developed specifically to assess HR-QOL for a specific condition. Possible consequences of PD have been assessed by generic instruments such as the Sickness Impact Profile (SIP), the Nottingham Health Profile (NHP), the Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey and also by disease-specific instruments; in particular, the Parkinson's Disease Quality-of-Life Questionnaire (PDQL) and 39-Item Parkinson's Disease Questionnaire (PDQ-39). This article summarises the criteria whereby such instruments should be evaluated by potential users and describes in more detail the methods of developing and testing such disease-specific instruments for use in PD. There is a range of valid and feasible methods available for taking into account patients' views of PD outcomes. These will become important outcome measures in future clinical trials of treatment regimes.

PubMed Disclaimer

References

    1. Neurology. 1967 May;17(5):427-42 - PubMed
    1. Arch Neurol. 1996 Sep;53(9):881-4 - PubMed
    1. Soc Sci Med. 1995 Nov;41(10 ):1447-62 - PubMed
    1. Mov Disord. 1998 May;13(3):406-13 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):381-9 - PubMed

Publication types

LinkOut - more resources